Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy

Abstract Background Contemporary data of peripheral T‐cell lymphoma (PTCL) and natural‐killer/T‐cell lymphoma (NKTL) patients treated with ifosfamide, carboplatin and etoposide (ICE) are limited. Aims We performed a retrospective analysis to estimate outcomes of ICE‐treated PTCL and NKTL patients at...

Full description

Bibliographic Details
Main Authors: Tricia Tay, Nagavalli Somasundaram, Cindy Lim, Lay Poh Khoo, Allan Zhi Kai Goh, Yuh Shan Lee, Xin Liu, Miriam Tao, Richard Quek, Mohamad Farid, Eileen Poon, Jason Y. S. Chan, Esther W. Y. Chang, Valerie S. W. Yang, Yeow Tee Goh, Daryl Tan, Colin Diong, Nicholas F. Grigoropoulos, Chandramouli Nagarajan, Michelle Poon, Sanjay deMel, Anand Jeyasekharan, Esther H. L. Chan, Joanne Lee, Yen Lin Chee, Soon Thye Lim, Tiffany Tang
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Cancer Reports
Subjects:
Asia
chemotherapy
haematology–oncology
natural‐killer/T‐cell lymphoma
T‐cell lymphoma
Online Access:https://doi.org/10.1002/cnr2.1552

Internet

https://doi.org/10.1002/cnr2.1552

Similar Items